| Abbreviation | Full Term/Definition |
| AMPK | Adenosine Monophosphate–Activated Protein Kinase |
| BMI | Body Mass Index |
| CGM | Continuous Glucose Monitoring |
| EMA/PRAC | European Medicines Agency/Pharmacovigilance Risk Assessment Committee |
| GI | Gastrointestinal |
| GLP-1 | Glucagon-Like Peptide-1 |
| GLP-1RA | Glucagon-Like Peptide-1 Receptor Agonist |
| HbA1c | Glycated Hemoglobin |
| IGF-1 | Insulin-Like Growth Factor-1 |
| IF | Intermittent Fasting |
| mTOR | Mammalian Target of Rapamycin |
| QALY | Quality-Adjusted Life Year |
| RA | Receptor Agonist |
| RCT | Randomized Controlled Trial |
| TRE | Time-Restricted Eating |
| T2DM | Type 2 Diabetes Mellitus |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.